Características clínicas, diagnósticas y pronosticas de pacientes con neumonía por Pneumocystis jiroveci en individuos infectados por virus de inmunodeficiencia humana e individuos inmunocomprometidos por otra etiología: comparative study of cases in HIV-infected patients and immunocompromised non-HIV-infected patients
Revista chilena de infectología · 2014-08 · 31 (4) · 417-424
DOI: 10.4067/s0716-10182014000400007 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Revista chilena de infectología, 2014-08. Verfasst von Inés Cerón und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Pneumocystis carinii. Die Arbeit wurde bisher 10-mal zitiert (Crossref).
Abstract (Originalsprache)
BACKGROUND: Although P. jiroveci pneumonia affects immunocompromised (IC) patients of any etiology, clinical features and prognostic outcomes are different depending if they are patients with HIV infection or other causes of IC. OBJECTIVES: To compare clinical and laboratory features as well as outcomes of P. jiroveci pneumonia in HIV versus non-HIV patients. METHODS: Retrospective review of clinical records of HIV and non-HIV patients with P. jiroveci pneumonia managed at the Hospital Clínico Universidad Católica in Santiago, Chile, between 2005 and 2007. RESULTS: We included 28 HIV and 45 non-HIV patients with confirmed P. jiroveci pneumonia. The non-HIV population was older (65 vs 36,2 years, p < 0,01), had shorter duration of symptoms (7 [1-21] vs 14 [2-45] days, p < 0,01), required more invasive techniques (60 vs 21%, p < 0,01) and RT-PCR to confirm the diagnosis (93 vs 68%, p < 0,01), were more frequently treated at intensive care units (58 vs. 25%, p < 0,01) requiring artificial ventilation (56 vs 11%, p < 0,01), and had a higher attributable mortality (33% vs 0%, p < 0,01). CONCLUSIONS: Our study confirmed that P. jiroveci pneumonia in non-HIV IC patients is more severe, more difficult to diagnose and has higher mortality that in HIV patients. Therefore, it is mandatory to optimize diagnostic and therapeutic strategies for this patients group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Zitieren
APA
Cerón, I., Rabagliati, R., Langhaus, J., Silva, F., Guzmán, A. M., & Lagos, M. (2014). Características clínicas, diagnósticas y pronosticas de pacientes con neumonía por Pneumocystis jiroveci en individuos infectados por virus de inmunodeficiencia humana e individuos inmunocomprometidos por otra etiología: comparative study of cases in HIV-infected patients and immunocompromised non-HIV-infected patients. Revista chilena de infectología, 31(4), 417-424. https://doi.org/10.4067/s0716-10182014000400007
Vancouver
Cerón I, Rabagliati R, Langhaus J, Silva F, Guzmán AM, Lagos M. Características clínicas, diagnósticas y pronosticas de pacientes con neumonía por Pneumocystis jiroveci en individuos infectados por virus de inmunodeficiencia humana e individuos inmunocomprometidos por otra etiología: comparative study of cases in HIV-infected patients and immunocompromised non-HIV-infected patients. Revista chilena de infectología. 2014;31(4):417-424. doi:10.4067/s0716-10182014000400007
BibTeX
@article{Cern2014,
author = {Cerón, Inés and Rabagliati, Ricardo and Langhaus, Javiera and Silva, Felipe and Guzmán, Ana M and Lagos, Marcela},
title = {Características clínicas, diagnósticas y pronosticas de pacientes con neumonía por Pneumocystis jiroveci en individuos infectados por virus de inmunodeficiencia humana e individuos inmunocomprometidos por otra etiología: comparative study of cases in HIV-infected patients and immunocompromised non-HIV-infected patients},
journal = {Revista chilena de infectología},
year = {2014},
volume = {31},
number = {4},
pages = {417--424},
doi = {10.4067/s0716-10182014000400007}
}
EUVIMED